rafivirumab structure
|
Common Name | rafivirumab | ||
---|---|---|---|---|
CAS Number | 944548-37-2 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of rafivirumabRafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails[1][2][3]. |
Name | rafivirumab |
---|
Description | Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | Rafivirumab 显示出对一系列 RABV 分离株的中和作用[2]。 Rafivirumab 与 RABV 糖蛋白的抗原位点 I 结合[3]。 Rafivirumab 完全中和野生型 ERA439 和 N336D R346K,EC50 范围在 3 到 5 pg/mL 之间[3]。 |
In Vivo | Rafivirumab (3-12 μg/kg,肌肉注射) 与 CR4098 一起提高了感染蝙蝠狂犬病病毒的叙利亚仓鼠的存活率[2]。 Animal Model: Syrian hamsters infected with bat rabies viruses[2]. Dosage: 6, 12, 16, 18 or 24 μg/kg of CL184 (mixture of Rafivirumab and CR4098 in 1:1 protein ratio) Administration: i.m. Result: Increased survival rate. |
References |
No Any Chemical & Physical Properties |